Edition:
India

Manas Mishra

Sarepta shares sink 14% after shock FDA rejection

20 Aug 2019

Shares of Sarepta Therapeutics Inc plunged 14% on Tuesday after the U.S. health regulator, in an unexpected move, declined to approve the drugmaker's newest treatment for a muscle-wasting disorder that mainly affects young boys.

Sarepta shares sink 17% after shock FDA rejection

20 Aug 2019

Aug 20 Shares of Sarepta Therapeutics Inc plummeted 17% on Tuesday after the U.S. health regulator, in a surprise move, declined to approve the drugmaker's newest treatment for a muscle-wasting disorder that mainly affects young boys.

FDA declines to approve Sarepta's second Duchenne treatment

20 Aug 2019

Sarepta Therapeutics Inc said on Monday the U.S. Food and Drug Administration declined to approve its newest treatment for Duchenne muscular dystrophy (DMD), citing safety concerns including the risk of infection and kidney toxicity.

Sick hospital workers often expose patients to contagious illness

17 Aug 2019

Hospital workers often come to work with contagious respiratory illnesses, against the recommendations of public health regulators, a Canadian study suggests.

FDA proposes graphic warnings on cigarette packs, advertisements

16 Aug 2019

The U.S. Food and Drug Administration has proposed that cigarette packs carry graphic new health warnings including pictures and text outlining lesser-known risks of smoking like bladder cancer and diabetes as well as lung cancer.

WeWork to test IPO investor appetite with widening losses

15 Aug 2019

WeWork owner The We Company published detailed financial statements for the first time on Wednesday, revealing breakneck revenue growth and soaring losses, as it prepares for an initial public offering as early as next month. | Video

Medical abortions can be safely supervised via telemedicine: study

14 Aug 2019

(Reuters Health) - Terminating a pregnancy with medication under virtual supervision from a clinician is just as effective and safe as doing so at a medical facility, a study across four U.S states suggests.

CVS Health raises 2019 profit forecast after beating profit estimates

08 Aug 2019

CVS Health Corp raised its full-year profit forecast and reported higher-than-expected second-quarter results on Wednesday, as increased U.S. prescription drug prices fueled rebates to its pharmacy benefits business.

UPDATE 4-CVS Health raises 2019 profit forecast after beating profit estimates

08 Aug 2019

Aug 7 CVS Health Corp raised its full-year profit forecast and reported higher-than-expected second-quarter results on Wednesday, as increased U.S. prescription drug prices fueled rebates to its pharmacy benefits business.

Cancer drug Keytruda, vaccines propel Merck to quarterly profit beat

30 Jul 2019

Merck & Co Inc reported better-than-expected second-quarter results on Tuesday and raised its full-year earnings forecast on strong demand for its blockbuster cancer immunotherapy Keytruda and vaccines.

World News

Hong Kong airport faces more protest turbulence

Hong Kong braced for multiple anti-government demonstrations on Friday and a "stress test" of the airport this weekend, as weeks of protest in the Chinese-ruled city showed no signs of let-up amid rising tension between China and some Western nations.